Connecticut doctors warn about a breakthrough cancer drug

The breakthrough drug Gleevec, which has been proven to stop the progress of CML: Chronic Myelogenous Leukemia, has now been found to possibly lead to congestive heart failure in some patients. A study

News 12 Staff

Jul 24, 2006, 11:35 PM

Updated 6,518 days ago

Share:

Connecticut doctors warn about a breakthrough cancer drug
The breakthrough drug Gleevec, which has been proven to stop the progress of CML: Chronic Myelogenous Leukemia, has now been found to possibly lead to congestive heart failure in some patients.
A study released by the Journal Nature was prompted after reports indicated that 10 patients on Gleevec developed severe heart failure. Officials and doctors in Connecticut say although this is a side effect of the drug, the negative does not outweigh the positive.
Novartis, the drug's maker, says this is a very rare side effect, but has placed a warning on the drug's label.


More from News 12